These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 15731485)
21. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men. St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904 [TBL] [Abstract][Full Text] [Related]
22. Advanced lipoprotein testing: recommendations based on current evidence. Lau JF; Smith DA Endocrinol Metab Clin North Am; 2009 Mar; 38(1):1-31. PubMed ID: 19217510 [TBL] [Abstract][Full Text] [Related]
23. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Ikewaki K; Schaefer JR; Frischmann ME; Okubo K; Hosoya T; Mochizuki S; Dieplinger B; Trenkwalder E; Schweer H; Kronenberg F; Koenig P; Dieplinger H Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2615-22. PubMed ID: 16195474 [TBL] [Abstract][Full Text] [Related]
24. The significance of low-density-lipoproteins size in vascular diseases. Rizzo M; Berneis K; Corrado E; Novo S Int Angiol; 2006 Mar; 25(1):4-9. PubMed ID: 16520717 [TBL] [Abstract][Full Text] [Related]
26. Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia. Tremblay AJ; Lamarche B; Cohn JS; Hogue JC; Couture P Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1101-6. PubMed ID: 16528005 [TBL] [Abstract][Full Text] [Related]
27. Should we measure routinely the LDL peak particle size? Rizzo M; Berneis K Int J Cardiol; 2006 Feb; 107(2):166-70. PubMed ID: 16412793 [TBL] [Abstract][Full Text] [Related]
28. Association between paraoxonase activity and lipid levels in patients with premature coronary artery disease. Sarkar PD; T M S; Madhusudhan B Clin Chim Acta; 2006 Nov; 373(1-2):77-81. PubMed ID: 16797516 [TBL] [Abstract][Full Text] [Related]
29. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013 [TBL] [Abstract][Full Text] [Related]
30. Trans fatty acids alter the lipid composition and size of apoB-100-containing lipoproteins secreted by HepG2 cells. Mitmesser SH; Carr TP J Nutr Biochem; 2005 Mar; 16(3):178-83. PubMed ID: 15741053 [TBL] [Abstract][Full Text] [Related]
31. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Papa A; Emdin M; Passino C; Michelassi C; Battaglia D; Cocci F Clin Chim Acta; 2008 Sep; 395(1-2):27-31. PubMed ID: 18498767 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation test of cadmium concentration influence on selected lipid metabolism parameters in smokers with stable coronary artery disease scheduled for coronary artery bypass grafting (CABG)]. Kleszczewska E; Lisowski P; Kleszczewski T; Adamczuk A; Trzciński R Przegl Lek; 2005; 62(10):1051-3. PubMed ID: 16521951 [TBL] [Abstract][Full Text] [Related]
33. Weighing in before the fight: low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy. Denke MA Circulation; 2005 Nov; 112(22):3368-70. PubMed ID: 16316961 [No Abstract] [Full Text] [Related]
34. Coronary artery calcium: should we rely on this surrogate marker? Redberg RF Circulation; 2006 Jan; 113(3):336-7. PubMed ID: 16432065 [No Abstract] [Full Text] [Related]
35. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993 [TBL] [Abstract][Full Text] [Related]
36. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy. Wiviott SD; Cannon CP Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906 [TBL] [Abstract][Full Text] [Related]
37. Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins from patients with coronary artery disease. Al-Benna S; Hamilton CA; McClure JD; Rogers PN; Berg GA; Ford I; Delles C; Dominiczak AF Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):218-23. PubMed ID: 16254199 [TBL] [Abstract][Full Text] [Related]
39. Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles. Lundahl B; Skoglund-Andersson C; Caslake M; Bedford D; Stewart P; Hamsten A; Packard CJ; Karpe F Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E739-45. PubMed ID: 16291571 [TBL] [Abstract][Full Text] [Related]
40. Comparison of apolipoprotein B and non-high-density lipoprotein cholesterol for identifying coronary artery disease risk based on receiver operating curve analysis. Levinson SS Am J Clin Pathol; 2007 Mar; 127(3):449-55. PubMed ID: 17276939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]